Table 1.
Sample description: demographic, clinical, and measured data
| Category | Figures or mean values |
|---|---|
| Number of patients | 52 |
| Age | 35.94±9.50 |
| Sex: men/women | 27/25 |
| Education: basic/vocational training/secondary/university | 8/19/16/9 |
| Occupation: yes/no/unknown | 26/25/1 |
| Pension: no/full/partial | 26/18/8 |
| Marital status: single/married/divorced/widowed | 36/9/5/2 |
| Partner: yes/no | 15/37 |
| Onset of the disorder: years | 29.24±9.48 |
| Number of hospitalizations | 3.36±3.01 |
| Length of the treatment | 7.04±8.17 |
| Positive family history: no/yes | 29/23 |
| objCGI-S | 2.74±0.99 |
| subjCGI-S | 2.30±1.43 |
| BDI-II | 15.04±10.30 |
| BAI | 12.31±9.88 |
| LSAS-total | 90.70±25.08 |
| Fear | 44.17±12.72 |
| Avoidance | 46.60±13.28 |
| ADHS-total | 39.76±11.02 |
| Pathway | 19.61±5.50 |
| Agency | 20.14±6.98 |
| DAI-10 | 3.96+3.69 |
| ISMI-total | 60.44±13.73 |
| Alienation | 12.66±4.07 |
| Stereotypes endorsement | 13.14±3.63 |
| Perceived discrimination | 9.88±3.22 |
| Social withdrawal | 12.32±3.55 |
| Stigma resistance | 12.52±2.35 |
| Novelty seeking | 96.12±10.80 |
| Harm avoidance | 110.62±19.44 |
| Reward dependence | 94.40±10.00 |
| Persistence | 104.58±18.08 |
| Self-directedness | 134.22±16.65 |
| Cooperativeness | 126.32±12.69 |
| Self-transcendence | 71.08±15.85 |
| Q-LES-Q-SUM | 271.24±58.57 |
| Q-LES-Q (%) | 58.00±13.00 |
| Physical health | 41.78±11.26 |
| Feelings | 45.90±11.93 |
| Work | 29.74±20.21 |
| Household | 33.44±13.66 |
| School | 13.94±10.16 |
| Leisure activities | 20.82±5.34 |
| Social relations | 35.92±9.48 |
| General | 49.70±12.23 |
| Antipsychotic index (calculated to risperidone daily dose) (n=49) | 5.55±3.81 |
| Antidepressant index (calculated to paroxetine daily dose) (n=23) | 27.83±12.23 |
| Anxiolytic index (calculated to diazepam daily dose) (n=7) | 9.29±4.50 |
Abbreviations: ADHS, Adult Dispositional Hope Scale; BAI, Beck Anxiety Inventory; BDI-II, Beck Depression Inventory-II; DAI-10, Drug Attitude Inventory 10; ISMI, Internalized Stigma of Mental Illness; LSAS, Liebowitz Social Anxiety Scale; objCGI-S, Clinical Global Impression Severity – the objective version; Q-LES-Q, Quality of Life Satisfaction and Enjoyment Questionnaire; Q-LES-Q-SUM, Quality of Life Satisfaction and Enjoyment Questionnaire total score; subjCGI-S, Clinical Global Impression Severity – the subjective version.